Efficacy of sustained-release vaginal oestriol in alleviating urogenital and systemic climacteric complaints.
In a double-blind, placebo-controlled study, 109 patients suffering from local and vasomotor postmenopausal complaints were randomly assigned to treatment with either depot vaginal suppositories containing 3.5 mg oestriol (E3) or a placebo. The treatment schedule comprised one vaginal suppository twice weekly for 3 weeks initially, followed by maintenance therapy with one vaginal suppository weekly for the 6-month study period. The effectiveness of the therapy was assessed on the basis of questionnaires (Kupperman index for vasomotor complaints and an original urogenital index for local complaints) and gynaecological examinations which included assessments of vaginal cytology, vaginal pH and Döderlein bacilli. To rule out induced endometrial proliferation, endometrial biopsies were performed in 50 women before and after the study. The vaginal depot (E3) formulation showed highly significant superiority over the placebo with respect to therapeutic effect on local urogenital complaints and alleviation of vasomotor complaints, including hot flushes. Analysis of the endometrial biopsies indicated that the monotherapy used caused no endometrial stimulation. Taking into account the minimal rate of adverse effects, the 3.5 mg E3 depot formulation studied represents a useful variant in the range of preparations available for the treatment of post-menopausal complaints.
Department of Biology, University of Liege, Belgium.
J M
JM
Foidart
J
J
Vervliet
P
P
Buytaert
D000282:Administration, Intravaginal; D000328:Adult; D000368:Aged; D001706:Biopsy; D002979:Climacteric / Q000187:drug effects*; D004311:Double-Blind Method; D004964:Estriol / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D052776:Female Urogenital Diseases / Q000188:drug therapy; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D008875:Middle Aged; D013488:Suppositories; D014621:Vagina / Q000187:drug effects / Q000473:pathology
D013488:Suppositories; D005640:Follicle Stimulating Hormone; D004964:Estriol